Profound Medical Corp (PRN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 287 | 305 | 299 | 287 | 277 |
| Accounts receivable | -841 | 854 | -801 | -128 | 573 |
| Accounts payable and accrued liabilities | 62 | -570 | 1,191 | -169 | 355 |
| Other Working Capital | -674 | 28 | 209 | 33 | 682 |
| Other Operating Activity | -5,184 | -5,715 | -7,915 | -4,361 | -7,006 |
| Operating Cash Flow | $-6,350 | $-5,098 | $-7,017 | $-4,338 | $-5,119 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -676 | -696 | -495 | -191 | -239 |
| Common Stock Issued | 0 | 22,938 | N/A | N/A | N/A |
| Other Financing Activity | 1 | -1,859 | 4 | 2 | 239 |
| Financing Cash Flow | $-675 | $20,383 | $-491 | $-189 | $0 |
| Exchange Rate Effect | -76 | -318 | 96 | -1,123 | 1,410 |
| Beginning Cash Position | 41,180 | 26,213 | 33,625 | 39,275 | 42,984 |
| End Cash Position | 34,079 | 41,180 | 26,213 | 33,625 | 39,275 |
| Net Cash Flow | $-7,025 | $15,285 | $-7,508 | $-4,527 | $-5,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,350 | -5,098 | -7,017 | -4,338 | -5,119 |
| Free Cash Flow | -6,350 | -5,098 | -7,017 | -4,338 | -5,119 |